Literature DB >> 26915978

Novel insights in drug metabolism by MS imaging.

Yutaka Sugihara1,2, Ken-Ichi Watanabe2,3, Ákos Végvári2,4.   

Abstract

During the last decade, lateral and temporal localization of drug compounds and their metabolites have been demonstrated and dynamically developed using MS imaging. The pharmaceutical industry has recognized the potential of the technology that provides simultaneous distribution and quantitative data. In this review, we present the latest technological achievements and summarize applications of drug imaging focusing on studies about metabolites by MALDI-MS imaging. We also introduce potential areas with pharmaceutical applications that are currently under exploration, including pharmacological, toxicological characterizations and metabolic enzyme localization in comparison with drug and metabolite distribution.

Keywords:  MS imaging; drug localization; drug metabolism; metabolic enzymes

Mesh:

Substances:

Year:  2016        PMID: 26915978     DOI: 10.4155/bio-2015-0020

Source DB:  PubMed          Journal:  Bioanalysis        ISSN: 1757-6180            Impact factor:   2.681


  3 in total

1.  The Role of Drug Metabolites in the Inhibition of Cytochrome P450 Enzymes.

Authors:  Momir Mikov; Maja Đanić; Nebojša Pavlović; Bojan Stanimirov; Svetlana Goločorbin-Kon; Karmen Stankov; Hani Al-Salami
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-12       Impact factor: 2.441

2.  Quantitative mass spectrometry imaging of drugs and metabolites: a multiplatform comparison.

Authors:  Lieke Lamont; Darya Hadavi; Brent Viehmann; Bryn Flinders; Ron M A Heeren; Rob J Vreeken; Tiffany Porta Siegel
Journal:  Anal Bioanal Chem       Date:  2021-03-26       Impact factor: 4.142

3.  Targeted Drug and Metabolite Imaging: Desorption Electrospray Ionization Combined with Triple Quadrupole Mass Spectrometry.

Authors:  Lieke Lamont; Gert B Eijkel; Emrys A Jones; Bryn Flinders; Shane R Ellis; Tiffany Porta Siegel; Ron M A Heeren; Rob J Vreeken
Journal:  Anal Chem       Date:  2018-11-06       Impact factor: 6.986

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.